
Axsome Therapeutics, Inc.
Axsome Therapeutics, Inc. (AXSM)
Price
Market cap
Next catalystExpected Q1 2027SUNOSI (solriamfetol) — ENGAGE and separate BED long-term study · Phase 3 dataCompany release ↗
Cash
Chart & Events
Core Clinical
PreINDP1P2FilingApproved
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Clinical
Upcoming clinical milestones
PreINDP1P2FilingApproved
Other pipelines
PreINDP2P3FilingApproved
PreINDP1P2P3FilingApproved
Approved / commercial
Approved
PreINDP1P2P3FilingApproved
Approved
PreINDP1P2P3FilingApproved
Approved
PreINDP1P2P3FilingApproved
Approved
PreINDP1P2P3FilingApproved
Approved
PreINDP1P2P3FilingApproved